Wave Life Sciences Ltd. (WVE)

Wave Life Sciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	200.35	88.5	150.56	184.5	147.16
Cash & Cash Equivalents	200.35	88.5	150.56	184.5	147.16
Cash Growth	126.39%	-41.22%	-18.39%	25.37%	-15.82%
Receivables	21.09	0	0	30	50
Other Current Assets	13.94	10.04	12	15.55	-11.69
Total Current Assets	235.37	98.54	162.56	230.04	185.48
Property, Plant & Equipment	35.72	44.13	40.64	45.43	54.47
Long-Term Investments	3.7	3.66	3.65	3.65	3.65
Other Long-Term Assets	0.16	0.06	0.15	0.12	40.66
Total Long-Term Assets	39.58	47.85	44.44	49.2	98.77
Total Assets	274.95	146.39	207.01	279.24	284.25
Accounts Payable	12.84	16.92	7.28	13.8	9.07
Deferred Revenue	165.66	111.33	114.58	133.04	153.12
Current Debt	6.71	5.5	4.96	3.71	3.24
Other Current Liabilities	1.23	-62.22	-62.62	-29.51	-47.28
Total Current Liabilities	186.44	71.52	64.2	121.04	118.15
Long-Term Debt	25.4	32.12	24.96	25.59	29.3
Other Long-Term Liabilities	15.6	79.96	77.48	41.96	65.19
Total Long-Term Liabilities	41.01	112.08	102.43	67.55	94.49
Total Liabilities	227.45	183.6	166.64	188.59	212.64
Total Debt	32.12	37.61	29.92	29.31	32.55
Debt Growth	-14.61%	25.73%	2.08%	-9.96%	-
Retained Earnings	-1,024.85	-967.34	-805.51	-683.27	-533.36
Comprehensive Income	-0.12	-0.03	0.18	0.39	0.27
Shareholders' Equity	39.63	-45.09	32.5	82.78	63.73
Net Cash / Debt	168.23	50.88	120.65	155.19	114.61
Net Cash / Debt Growth	230.63%	-57.83%	-22.26%	35.40%	-34.44%
Net Cash Per Share	1.59	0.65	2.33	3.96	3.38
Working Capital	48.93	27.02	98.36	109	67.32
Book Value Per Share	0.37	-0.57	0.63	2.11	1.88

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).